Skip to main content
The Egyptian Heart Journal

Table 3 Clinical characterestics, co-morbidities and medications in HFrEF and HFpEF subgroups

From: Clinical characteristics and in-hospital outcome of heart failure in women: a single center registry from Egyptian cardiac care unit

 

HFrEF, n = 73

HFpEF, n = 45

P value

Age (years)

66.9 ± 9

52.3 ± 11

0.0001

Chest pain (CP)

22 (30%)

1 (2.22%)

0.001

Killip class

   

 I

7 (9.6%)

4 (9%)

0.935

 II

4 (5.5%)

2 (4.44%)

0.915

 III

16 (22%)

11 (24.44%)

0.887

 IV

44 (60.3%)

27 (60%)

0.941

Orthopnea

50 (68.5%)

30 (66.67%)

0.932

PND

12 (16.4%)

4 (9%)

0.488

Palpitations

3 (4.12%)

11 (24.44%)

0.004

Syncope

1 (1.4%)

0 (0%)

0.692

Cough dry

3 (4.12%)

5 (11.11%)

0.142

Productive cough

19 (26%)

11 (24.44%)

0.339

Edema

26 (35.6%)

12 (26.67%)

0.256

Previous MI

13 (17.8%)

6 (13.33%)

0.500

Previous PCI

9 (12.3%)

3(6.67%)

0.380

Previous CABG

7 (9.6%)

1(2.22%)

0.190

Valve surgery

1 (1.4%)

5(11.11%)

0.035

STEMI

16 (21.9%)

0 (0%)

0.002

STEMI

16 (21.9%)

0 (0%)

0.002

UA/NSTEMI

8 (11%)

13(28.9%)

0.000

CHB

1 (1.34%)

0 (0%)

0.436

AF/flutter

10 (13.7%)

12 (26.6%)

0.039

IE

0 (0%)

1 (2.2%)

0.077

PE

1 (1.34%)

2 (4.44%)

0.303

Aortic dissection

1 (1.34%)

2 (4.44%)

0.303

Hypertension

4(5.5%)

11(24.44%)

0.000

Prior HF

20 ( 27%)

8 (17.78%)

0.000

RHD

0 (0%)

4 (8.89%)

0.000

Pacemaker

1 (1.4%)

2 (4.44%)

0.108

ICD

1 (1.4%)

0 (0%)

0.436

CVP

52 (71.2%)

19 (42.2%)

0.002

Endotracheal intubation

15 (20.5%)

0 (0%)

0.001

Thazides

22 (12.4%)

8 (6.8%)

0.119

Loop diuretics

109 (61%)

68 (57.6%)

0.535

Nitrates

103 (58%)

67 (56.78%)

0.853

Warfarin

63 (35.4%)

31 (26.3%)

0.099

Clopedogril

75 (42.1%)

58 (49.2%)

0.235

Hospital stay

7.88 ± 5.7

5.73 ± 3.4

0.02

Sepsis

1 (1.4%)

2 (4.4%)

0.303

Pneumonia

4 (5.5%)

2 (4.44%)

0.575

Fever

0 (0%)

1 (2.22%)

0.172

Hemoptesis

1 (1.4%)

0 (0.85%)

 

Lanoxin toxicisty

0 (0%)

0 (0%)

1 (2.22%)

1 (2.22%)

 

CKD/ESRD

3 (4.12%)

0 (0%)

0.236

Respiratory failure

2 (2.7%)

2 (4.44%)

0.511

liver failure

3 (4.12%)

6 (13.3%)

0.067

Tamponade

1 (1.4%)

2 (4.44%)

0.303

GIT bleeding

1 (1.4%)

2 (4.44%)

0.303

CCI

71 (97.3%)

41 (91%)

0.140

Previous MI

13 (17.8%)

4 (4.44%)

0.261

AKI

12 (16.4%)

0 (0%)

0.016

PVD

1 (1.4%)

1 (2.22%)

0.549

CVA/TIA

7 (9.6%)

3 (6.7%)

0.518

Hemiplegia

2 (2.7%)

0 (0%)

0.322

COPD

7 (9.6%)

3 (6.67%)

0.056

Autoimmune

8 (11%)

0 (0%)

0.046

Mild liver diseases

1 (1.4%)

0 (0%)

0.436

peptic ulcer

0 (0%)

1 (2.22%)

0.254

Cancer

1 (1.4%)

0 (0%)

0.436

Metasis

1 (1.4%)

2 (4.4%)

0.303

Dementia

1 (1.4%)

2 (4.44%)

0.336

Rheumatic D

1 (1.4%)

2 (4.4%)

0.303

HIV

0 (0%)

1 (2.22%)

0.254

Cellulitis

3 (4.12%)

6 (13.%)

0.067

Depression

0 (0%)

2 (4.4%)

0.108

Mechanical ventilation

14 (19.2%)

1 (2.22%)

0.007

Pricardiocentesis

0 (0%)

1 (2.22%)

0.201

PCI

7 (9.6%)

0 (0%)

0.032

Coronary angiography

5 (6.8%)

0 (0%)

0.073

Amiodarone

17 (9.6%)

7 (14.4%)

0.200

Unfractunated heparin

62 (34.8%)

34(28.8%)

0.279

LMWH

100 (56.2%)

79 (67%)

0.064

Lytic therapy

45 (25.3%)

32 (27.1%)

0.724

Mortality

12 (16.4%)

1 (2.22%)

0.01

  1. BMI body mass index, DM diabetes mellitus, HTN hypertension, STEMI ST segment elevation myocardial infarction, UA unstable angina, IE infective endocarditis, PE pulmonary embolism, CHB complete heart block, Af atrial flutter, AF atrial fibrillation, PCI percutaneous coronary intervention, CA coronary angiography, CVA cerebrovascular accident, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure
Back to article page